Highlights Hester Biosciences Limited

Equities

HESTERBIO

INE782E01017

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 03:30:55 17/04/2026 pm IST			5-day change	1st Jan Change
1,492.80 ^INR	+1.41%		+2.95%	-6.23%

11/03	Hester Biosciences Gets Board Nod to Divest 43.8% Stake in Subsidiary; Shares Up 3%	MT
11/03	Hester Biosciences approves divestment of 43.81% equity in Texas Lifesciences	RE

Highlights

11/03	Hester Biosciences Gets Board Nod to Divest 43.8% Stake in Subsidiary; Shares Up 3%	MT
11/03	Hester Biosciences approves divestment of 43.81% equity in Texas Lifesciences	RE
11/03	Ticop Life Private Limited entered into an agreement to acquire an additional 43.81% stake in Texas Laboratories from Hester Biosciences Limited for INR 92 million.	CI
30/01	Hester Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
30/01	Hester Biosciences re-appoints Rajiv Gandhi as CEO & MD	RE
20/11	Hester Biosciences says Ashish Desai appointed as chief financial officer	RE
12/11	Indian Equities Extend Winning Run on NDA Exit Poll Boost, Global Optimism	MT
12/11	Hester Biosciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
12/11	Hester Biosciences' Consolidated Profit Declines in Fiscal Q2; Shares Down 3%	MT
06/25/06	For final dividend	FA
01/25/01	Hester Biosciences Consolidated Net Profit Jumps in Fiscal Q1; Shares Jump 12%	MT
01/25/01	Hester Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
09/25/09	Hester Biosciences Limited Proposes Dividend for the Financial Year Ended 31 March 2025, Payable on or After19 August 2025	CI
09/25/09	Hester Biosciences Limited Reports Earnings Results for the Full Year Ended March 31, 2025	CI
30/25/30	Hester Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	CI
28/24/28	Hester Biosciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	CI
22/24/22	For final dividend	FA
02/24/02	Hester Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2024	CI
10/24/10	Hester Biosciences' Consolidated Net Profit Rises in Fiscal Q4; Shares Jump 4%	MT
10/24/10	Hester Biosciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
10/24/10	Hester Biosciences Limited Proposes Dividend for the Financial Year 2023- 24	CI
29/24/29	Hester Biosciences Limited Announces Executive Changes	CI
02/24/02	Hester Biosciences Sees Sharp Decline in Fiscal Q3 Consolidated Profit	MT
02/24/02	Hester Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
07/23/07	Hester Biosciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	CI